Leiomyosarcoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2018-06-29
FDA Approved: YONDELIS — Supplemental Application (Janssen Products, LP)
FDA approved a supplemental application for YONDELIS (trabectedin) from Janssen Products, LP.